Investigator global evaluations of efficacy of injectable poly-l-lactic acid versus human collagen in the correction of nasolabial fold wrinkles

Aesthetic Surgery Journal

Volumn 31, Issue 5, 2011, Pages 521-528

  Brandt, Fredric S ^a   Cazzaniga, Alex ^a   Baumann, Leslie ^b   Fagien, Steven ^a   Glazer, Scott ^a   Kenkel, Jeffrey M ^c   Lowe, Nicholas J ^d   Monheit, Gary D ^e   Narins, Rhoda S ^f   Rendon, Marta I ^a   Rohrich, Rod J ^c   Werschler, William Philip ^g  

^a University of Miami ^*

^b UNIVERSITY OF MIAMI   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^f NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

collagen; cosmetic medicine; nasolabial folds; PLLA; poly L lactic acid

Indexed keywords

COLLAGEN IMPLANT; POLYLACTIC ACID;

ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FACE DEFORMITY; FEMALE; FOLLOW UP; HUMAN; INJECTION SITE ERYTHEMA; INJECTION SITE PAIN; INJECTION SITE PRURITUS; INVESTIGATOR GLOBAL EVALUATION SCORE; LIPOATROPHY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NASOLABIAL FOLD WRINKLE; PATIENT SAFETY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; WRINKLE;

EID: 79960201132     PISSN: 1090820X     EISSN: 1527330X     Source Type: Journal    
DOI: 10.1177/1090820X11411161     Document Type: Article

References (26)

1. American Society for Aesthetic Plastic Surgery 2010 Cosmetic Surgery National Databank Statistics. Available at: http://www.surgery.org/sites/ default/files/Stats2010-1.pdf
2. Narins RS, Brandt F, Leyden J, Lorenc ZP, Rubin M, Smith S. A randomized, double-blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds. Dermatol Surg. 2003 ; 29 (6). 588-595 (Pubitemid 36702442)
3. Jacovella PF, Peiretti CB, Cunille D, Salzamendi M, Schechtel SA. Long-lasting results with hydroxylapatite (Radiesse) facial filler. Plast Reconstr Surg. 2006 ; 118 (3). 15S - 21S (Pubitemid 44319086)
4. Carruthers A, Carey W, De Lorenzi C, Remington K, Schachter D, Sapra S. Randomized, double-blind comparison of the efficacy of two hyaluronic acid derivatives, Restylane Perlane and Hylaform, in the treatment of nasolabial folds. Dermatol Surg. 2005 ; 31 (11, pt 2). 1591-1598
5. Juvéderm Ultra Plus [package insert]. Santa Barbara, CA: Allergan, Inc.; 2008.
6. Radiesse Injectable implant [package insert]. Franksville, WI: BioForm Medical, Inc.; 2006.
7. Sadick NS, Burgess C. Clinical experience of adverse outcomes associated with poly-L-lactic acid. J Drugs Dermatol. 2007 ; 6 (1). S4 - S8
8. Keni SP, Sidle DM. Sculptra (injectable poly-L-lactic acid). Facial Plast Surg Clin North Am. 2007 ; 15 (1). 91 vii - 97 (Pubitemid 46275944)
9. Sculptra Aesthetic [prescribing information]. Bridgewater, NJ: Dermik Laboratories; 2009.
10. Sculptra [prescribing information]. Bridgewater, NJ: Dermik Laboratories; a business of sanofi-aventis U.S. LLC; 2006.
11. Valantin MA, Aubron-Olivier C, Ghosn J, et al. Polylactic acid implants (New-Fill) to correct facial lipoatrophy in HIV-infected patients: results of the open-label study VEGA. AIDS. 2003 ; 17 (17). 2471-2477 (Pubitemid 38393319)
12. Moyle GJ, Brown S, Lysakova L, Barton SE. Long-term safety and efficacy of poly-L-lactic acid in the treatment of HIV-related facial lipoatrophy. HIV Med. 2006 ; 7 (3). 181-185 (Pubitemid 43337597)
13. Butterwick K. Understanding injectable poly-l-lactic acid. Cosmet Dermatol. 2007 ; 20 (6). 388-392 (Pubitemid 46983288)
14. Narins RS, Baumann L, Brandt FS, et al. A randomized study of the safety and efficacy of injectable poly-L-lactic acid versus human-based collagen implant in the treatment of nasolabial fold wrinkles. J Am Acad Dermatol. 2010 ; 62 (3). 448-462
15. Salles AG, Lotierzo PH, Gimenez R, Camargo CP, Ferreira MC. Evaluation of the poly-L-lactic acid implant for treatment of the nasolabial fold: 3-year follow-up evaluation. Aesthetic Plast Surg. 2008 ; 32 (5). 753-756
16. Mest DR, Humble G. Safety and efficacy of poly-L-lactic acid injections in persons with HIV-associated lipoatrophy: the US experience. Dermatol Surg. 2006 ; 32 (11). 1336-1345 (Pubitemid 44691136)
17. Negredo E, Higueras C, Adell X, et al. Reconstructive treatment for antiretroviral-associated facial lipoatrophy: a prospective study comparing autologous fat and synthetic substances. AIDS Patient Care STDS. 2006 ; 20 (12). 829-837 (Pubitemid 46106070)
18. Murray CA, Zloty D, Warshawski L. The evolution of soft tissue fillers in clinical practice. Dermatol Clin. 2005 ; 23 (2). 343-363
19. Glavas IP. Filling agents. Ophthalmol Clin North Am. 2005 ; 18 (2). 249-257 (Pubitemid 40789947)
20. Mest DR, Humble GM. Retreatment with injectable poly-L-lactic acid for HIV-associated facial lipoatrophy: 24-month extension of the Blue Pacific Study. Dermatol Surg. 2009 ; 35 (suppl 1). 350-359
21. Hanke CW, Redbord KP. Safety and efficacy of poly-L-lactic acid in HIV lipoatrophy and lipoatrophy of aging. J Drugs Dermatol. 2007 ; 6 (2). 123-128
22. Burgess CM, Quiroga RM. Assessment of the safety and efficacy of poly-L-lactic acid for the treatment of HIV-associated facial lipoatrophy. J Am Acad Dermatol. 2005 ; 52 (2). 233-239
23. Woerle B, Hanke CW, Sattler G. Poly-L-lactic acid: a temporary filler for soft tissue augmentation. J Drugs Dermatol. 2004 ; 3 (4). 385-389
24. Cosmoplast [prescribing information]. Santa Barbara, CA: Allergan, Inc.; 2007.
25. Moyle GJ, Lysakova L, Brown S, et al. A randomized open-label study of immediate versus delayed polylactic acid injections for the cosmetic management of facial lipoatrophy in persons with HIV infection. HIV Med. 2004 ; 5 (2). 82-87 (Pubitemid 38404660)
26. Butterwick K, Lowe NJ. Injectable poly-L-lactic acid for cosmetic enhancement: learning from the European experience. J Am Acad Dermatol. 2009 ; 61 (2). 281-293